NNK
| Template:Chembox header| NNK | |
|---|---|
| NNK | |
| Chemical name | 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone |
| Molecular formula | C10H13N3O2 |
| Molar mass | 207.23 g/mol |
| CAS number | [64091-91-4] |
|
WikiDoc Resources for NNK |
|
Articles |
|---|
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on NNK at Clinical Trials.gov Clinical Trials on NNK at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on NNK
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Directions to Hospitals Treating NNK Risk calculators and risk factors for NNK
|
|
Healthcare Provider Resources |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (abbreviated NNK) is a nitrosamine present in tobacco that is a potent procarcinogen. It is activated by CYP2A6. It is a biomarker of exposure to cigarette smoke. It is produced upon the curing of tobacco.
External links